Table 3.
Guidelines | QRSd (ms) | QRS Morphology | EFa | ICMb | NYHAc Class | CORd | Recommendation | Female QRSd (ms) |
---|---|---|---|---|---|---|---|---|
ESC 2016 (2) | >130 | LBBB | <35% | I | Recommend CRT | >118 | ||
>130 | non-LBBB | <35% | II a | Consider CRT | >120 | |||
<130 | <35% | III | Contraindicated | <120 | ||||
ACCF/AHA 2013 (1) | >150 | LBBB | <35% | II, III, IV | I | Recommend CRT | >137 | |
>150 | non-LBBB | <35% | II | II a | Can be useful | >138 | ||
120–149 | LBBB | <35% | II, III, IV | II a | Can be useful | 109–136 | ||
120–149 | non-LBBB | <35% | III, IV | II b | May be considered | 111–137 | ||
>150 | non-LBBB | <35% | II | II b | May be considered | >138 | ||
>150 | LBBB | <30% | ICM | II b | May be considered | >137 | ||
<150 | non-LBBB | <35% | I or II | III | Contraindicated | <138 |
EF, Ejection fraction.
ICM, Ischemic Cardiomyopathy.
NYHA Class, New York Heart Association Functional Classification.
COR, class of recommendation.